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Leucine carboxyl methyltransferase-1 (LCMT1) and protein phosphatase methylesterase-1 (PME-1) are essential
enzymes that regulate the methylation of the protein phosphatase 2A catalytic subunit (PP2AC). LCMT1 and PME-1
have been linked to the regulation of cell growth and proliferation, but the underlying mechanisms have remained
elusive. We show here an important role for an LCMT1-PME-1 methylation equilibrium in controlling mitotic spindle
size. Depletion of LCMT1 or overexpression of PME-1 led to long spindles. In contrast, depletion of PME-1,
pharmacological inhibition of PME-1 or overexpression of LCMT1 led to short spindles. Furthermore, perturbation of the
LCMT1-PME-1 methylation equilibrium led to mitotic arrest, spindle assembly checkpoint activation, defective cell
divisions, induction of apoptosis and reduced cell viability. Thus, we propose that the LCMT1-PME-1 methylation
equilibrium is critical for regulating mitotic spindle size and thereby proper cell division.
Introduction
Leucine carboxyl methyltransferase-1 (LCMT1) is a mono-
meric 38-kDa protein that catalyzes the transfer of methyl groups
from S-Adenosyl-L-Methionine (SAM) to the a-carboxyl leucine
of the catalytic subunit of protein phosphatase 2A (PP2AC).1
The PP2A phosphatase has established roles in cell signaling and
cell proliferation, and is composed of a scaffold subunit (A sub-
unit), a catalytic subunit (C subunit), and one of many regulatory
subunits (B, B0, B00, B000 subunits) that provide substrate specific-
ity and generate >60 PP2A holoenzymes.2,3 Methylation of
PP2AC controls its association with specific regulatory subunits
(B subunits), thus modulating PP2A activity toward specific sub-
strates.2,4 This methylation is reversible by the protein phospha-
tase methylesterase-1 (PME-1).5,6 Other than PP2AC, there are
no known substrates of LCMT1 or PME-1, thus it has been
hypothesized that the main role of these enzymes is to regulate
the abundance of specific PP2A holoenzymes. Interestingly,
homozygous deletion of either LCMT1 or PME-1 in mice is
embryonic lethal, indicating that their role in regulating PP2A
through methylation/demethylation is critical for cell growth and
development.7,8
A recent report demonstrated that depletion of LCMT1
led to an abnormal progression through mitosis and an
increase in cell death,7 thus implicating LCMT1 in the regu-
lation of normal cell division and survival. However, the
mechanism of how LCMT1 functions to promote proper cell
division has remained elusive. As PME-1 counteracts
LCMT1 methylation activity, it is reasonable to postulate
that PME-1 might also have a role in regulating cell division.
However, this hypothesis has also remained unexplored. In
this study, we have analyzed the role of LCMT1 and PME-1
in cell division. Surprisingly, we uncovered a previously
undescribed methylation equilibrium established by LCMT1
and PME-1 that is critical for regulating mitotic spindle size,
and its misregulation leads to defective cell divisions and
reduced cell viability.
Results
Perturbation of the LCMT1-PME-1 methylation
equilibrium leads to an abnormal mitotic spindle size
To define the role of LCMT1 in cell division and to determine if
PME-1 was required for proper cell division, we analyzed the cellu-
lar consequences of depleting LCMT1 and PME-1. First, we veri-
fied that siRNA oligonucleotides targeting LCMT1 (siLCMT1)
and PME-1 (siPME-1) were able to deplete LCMT1 and PME-1
protein levels compared to non-targeting siRNAs (siControl)
(Fig. 1A; Fig. S1). Human HeLa cells were then transfected with
siControl, siLCMT1, or siPME-1 for 48 hours. Cells were fixed,
costained for DNA, a-tubulin and Pericentrin, and imaged by
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fluorescence microscopy (Fig. 1B). Interestingly, depletion of
LCMT1 led to abnormally long spindles with spindle multipolarity
and aberrant unaligned chromosomes (Fig. 1B; Fig. S2). Con-
versely, depletion of PME-1 led to abnormally short spindles and
partially aligned chromosomes at the metaphase plate (Fig. 1B;
Fig. S2). Quantitative analysis of these data showed that depletion
of both LCMT1 and PME-1 led to a major increase in the percent-
age of mitotic cells (siLCMT1D 33.6 § 3.7 (p D 0.0011) and
siPME-1D 30.3 § 6.0 (p D 0.033) compared to siControl D
8.7 § 1.7) (Fig. 1C), aberrant mitotic spindles (siLCMT1
Figure 1. For figure legend, see page 1951.
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displayed predominantly long spindles D 27.7§ 2.1 (p D 0.0008)
and multipolar spindles D 30.3 § 2.0 (p D 0.0014) compared to
siControlD 4.3§ 1.2 and 9.7§ 1.7 respectively and siPME-1 dis-
played predominantly short spindles D 41.3 § 2.9 (p D 0.0001)
compared to siControl D 4.6 § 0.9) (Fig. 1D), and an increase in
the percentage of cells with unaligned chromosomes (siLCMT1D
53 § 5.1 (p D 0.0027) and siPME-1D 51 § 2.2 (p D 0.0001)
compared to siControl D 7 § 2.2) (Fig. 1E). These data indicated
that LCMT1 and PME-1 likely played a role in regulating mitotic
spindle size and that depletion of either led to defects in spindle size
and assembly.
Since depletion of LCMT1 and PME-1 appeared to have
opposing effects on spindle length, we analyzed this in more detail
by measuring the pole-to-pole (PTP) distance of siControl,
siLCMT1 or siPME-1 metaphase spindles (Fig. 1F and G). siCon-
trol cells had a PTP distance of 11.2 mm§ .45, whereas siLCMT1
metaphase spindles were longer (13.8 mm§ .49, pD 0.0056) and
those of siPME-1 were shorter (7.5 mm § .32, p D 0.0041)
(Fig. 1G). However, siLCMT1 cells had a similar spindle width
(8.9 mm § .15) to siControl cells (8.9 mm § .24), whereas the
spindle width of siPME-1 cells was shorter (5.6 mm § .3, p D
0.0007) (Fig. 1H). Nonetheless, the total spindle volume was
abnormally large for siLCMT1 mitotic spindles (569.7 mm3 §
38.7, pD 0.0366) and abnormally small for siPME-1 mitotic spin-
dles (125.7 mm3 § 14.9, p D 0.0024), compared to siControl
mitotic spindles (466.3 mm3 § 38.8) (Fig. 1I). These data indi-
cated that LCMT1 and PME-1 were indeed regulating mitotic
spindle size. Consistently, there was also an increase in the total
amount of microtubule polymer (total fluorescence intensity of
spindle microtubules in arbitrary units, A.U.) for siLCMT1 (606
A.U. § 34, p D 0.025) and a decrease in microtubule polymer for
siPME-1 (253 A.U.§ 50, p D 0.049) compared to siControl (434
A.U. § 37) (Fig. 1J). Together, these results indicated that a bal-
ance between LCMT1 methylation and PME-1 demethylation was
responsible for regulating spindle size, potentially through the mod-
ulation of PP2AC methylation (Fig. 1K). In support of this idea,
siLCMT1 led to an increase in the ratio of demethylated
PP2AC (siControlD1 § .3, siLCMT1D1.6 § .07) whereas
siPME-1 led to a decrease in the ratio of demethylated
PP2AC (siControlD1 § .12, siPME-1D 0.6 § .13), consis-
tent with previous reports (Fig. 1A; Fig. S3A and B).4,9
Pharmacological inhibition of PME-1 leads to short mitotic
spindles
Due to the recent availability of a PME-1 specific inhibitor
(AMZ30),10,11 we sought to further test this hypothesis through
pharmacological inhibition of PME-1. HeLa cells were synchro-
nized in G1/S and released into the cell cycle in the presence of
control DMSO or AMZ30 for 9 hours, and then processed for
quantitative immunofluorescence analyses of spindle morphol-
ogy, size, width, and volume as described above. Consistent with
our previous results with siRNA-mediated depletion of PME-1,
treatment of cells with AMZ30 led to a decrease in the ratio of
demethylated PP2AC (ControlD1 § .06, AMZ30D0.3 § .01)
(Fig. 2A; Fig. S3C), an increase in the percentage of cells
arrested in mitosis (46 § 3.7, p D 0.001) compared to DMSO
(10 § 2.2) (Fig. 2B and C), an increase in the percentage of
mitotic cells with spindle defects (predominantly abnormally
small metaphase spindles (61.3 § 6.6, p D 0 .0003) compared
to DMSO (6.0 § 1.6)) (Fig. 2B and D), an increase in the per-
centage of cells with unaligned chromosomes (78 § 5.4, p D
0.0001) compared to DMSO (12 § 2.2) (Fig. 2B and E; Fig.
S2), a reduced PTP distance (6.1 mm § .49, p D 0.014) com-
pared to DMSO (10.9 mm § .42) (Fig. 2F), a reduced spindle
width (6.7 mm § .17, p D 0.0009) compared to DMSO
(8.4 mm § .02) (Fig. 2G), a reduced spindle volume
(121 mm3 § 40, p D 0.0006) compared to DMSO
(400.1 mm3 § 16.5) (Fig. 2H), and a decrease in the amount of
microtubule polymer (total fluorescence intensity of spindle
microtubules in arbitrary units, A.U.) (247 A.U. § 42, p D
0.027) compared to DMSO (418 A.U. § 57) (Fig. 2I). There-
fore, the results of inhibiting PME-1 pharmacologically were
consistent with the results of depleting PME-1 and further sup-
ported the hypothesis that misregulation of the LCMT1-PME-1
methylation equilibrium led to an abnormal spindle size.
Perturbation of the LCMT1-PME-1 methylation
equilibrium by overexpressing LCMT1 or PME-1 leads to an
abnormal mitotic spindle size
To further test this hypothesis, we generated doxycycline
(Dox) inducible localization and affinity purification (LAP)
tagged LCMT1 and PME-1 HeLa stable cell lines that expressed
either LAP-LCMT1 or LAP-PME-1 from a single locus within
Figure 1 (See previous page). RNAi-mediated perturbation of the LCMT1-PME-1 methylation equilibrium leads to misregulation of spindle size and cell
division. (A) siRNA knockdown of LCMT1 or PME-1 expression levels compared to control non-targeting siRNA. Note that the levels of demethylated
PP2AC decreases in PME-1 depleted cells and increases in LCMT1 depleted cells. (B) Immunofluorescence microcopy showing that PME-1 depletion leads
to abnormally short spindles and LCMT1 depletion leads to abnormally long spindles. Bar D 5 mm. (C) Quantification of the percentage of cells in mitosis
showing that depletion of LCMT1 or PME-1 leads to a major increase in cells arrested in mitosis. (D) Quantification of the percentage of mitotic cells with
abnormal spindles (short, long, multipolar) showing that depletion of LCMT1 or PME-1 leads to a major increase in abnormal spindles. (E) Quantification
of the percentage of mitotic cells with unaligned chromosomes showing that depletion of LCMT1 or PME-1 leads to a major increase in unaligned chro-
mosomes. (F) Outline of metaphase spindle pole-to-pole (PTP) distance and width measurements. (G) Quantification of metaphase spindle PTP distance
(in mm) showing that depletion of PME-1 leads to abnormally short spindles and depletion of LCMT1 depletion leads to abnormally long spindles. (H)
Quantification of metaphase spindle width (in mm) showing that depletion of PME-1 leads to abnormally short spindle widths, while depletion of LCMT1
had no significant effect on spindle width. (I) Quantification of metaphase spindle volume (in mm3) showing that depletion of PME-1 leads to a decrease
in volume and depletion of LCMT1 leads to an increase in volume. (J) Quantification of the total fluorescence intensity of mitotic spindle microtubules
for PME-1 or LCMT1-depleted cells, in arbitrary units (A.U.), showing that depletion of PME-1 leads to a decrease in total microtubule polymer, whereas
depletion of LCMT1 leads to an increase in total microtubule polymer. (K) Model of the LCMT1-PME-1 methylation equilibrium that regulates spindle size
and normal cell division. (C, D, F–J) Data represents average § SDs of 3 independent experiments. * D P < 0.05, ** D P < 0.005, *** D P < 0.0005, ns D
not statistically significant.
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the genome.12 These cell lines were used to analyze the effects of
overexpressing LAP-LCMT1 or LAP-PME-1 on spindle size and
morphology. Briefly, cells were treated with Dox for 24 hours to
induce LAP-LCMT1 or LAP-PME-1 overexpression. Cells were
then harvested and protein extracts were analyzed by immuno-
blot analysis (Fig. 3A). In parallel experiments, cells overexpress-
ing LAP-LCMT1 or LAP-PME-1 were fixed, stained, and their
mitotic defects, spindle size, and spindle volume were analyzed
by immunofluorescence microscopy as described above. These
analyses showed that overexpression of LAP-PME-1 led to longer
spindles with spindle multipolarity and unaligned chromosomes
(Fig. 3B; Fig. S2). Conversely, overexpression of LAP-LCMT1
led to shorter spindles with chromosomes partially aligned at the
metaphase plate (Fig. 3B; Fig. S2). Quantitative analysis of these
data showed that overexpression of LAP-LCMT1 or LAP-PME-
1 led to a major increase in the percentage of cells arrested in
mitosis (LAP-LCMT1D 34.3 § 7.9 (pp D 0 .01) and LAP-
PME-1D 36.0 § 2.4 (p D 0.0002) compared to Control D
Figure 2. Pharmacological-mediated perturbation of the LCMT1-PME-1 methylation equilibrium leads to misregulation of spindle size and cell division.
(A) Pharmacological inhibition of PME-1 with AMZ30 compared to DMSO vehicle control. Note that the levels of demethylated PP2AC decreased in cells
treated with AMZ30. (B) Immunofluorescence microcopy showing that AMZ30-treated cells have abnormally short spindles. Bar D 5 mm. (C) Quantifica-
tion of the percentage of cells in mitosis showing that inhibition of PME-1 with AMZ30 leads to a major increase in cells arrested in mitosis. (D) Quantifi-
cation showing that treatment of cells with AMZ30 leads to a major increase in the percentage of mitotic cells with abnormal spindles (short, long,
multipolar). (E) Quantification showing that treatment of cells with AMZ30 leads to a major increase in the percentage of unaligned chromosomes. (F)
Quantification of metaphase spindle PTP distance (in mm) showing that AMZ30-treated cells have abnormally short spindles. (G) Quantification of meta-
phase spindle width (in mm) showing that AMZ30-treated cells have abnormally short spindle widths. (H) Quantification of metaphase spindle volume
(in mm3) showing that treatment with AMZ30 leads to a decrease in volume. (I) Quantification of the total fluorescence intensity of mitotic spindle micro-
tubules for AMZ30-treated cells, in arbitrary units (A.U.), showing that AMZ30 treatment leads to a decrease in total microtubule polymer. (C–I) Data rep-
resents average § SDs of 3 independent experiments. **D P< 0.005, *** D P < 0.0005.
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10.0 § 1.6) (Fig. 3C), an increase in the percentage of cells with
abnormal mitotic spindles (short, long, multipolar) (predomi-
nantly short spindles for LAP-LCMT1D 39.3 § 4.2 (p D
0.0028) compared to Control D 4.7 § 1.2 and long spindles D
28.0 § 4.9 (p D 0.0026) and multipolar spindles D 29.7 § 3.4
(p D 0.0086) for LAP-PME-1 compared to Control D 6.0 § 1.6
and 9.3 § 1.2 respectively) (Fig. 3D), and an increase in the per-
centage of cells with partially unaligned chromosomes (LAP-
LCMT1D 28.3 § 4.5 (p D 0.0052) and LAP-PME-1D 46.7 §
2.9 (p D 0.0002) compared to Control D 12 § 1.4) (Fig. 3E).
Consistent with our previous results, control cells had a PTP dis-
tance of 10.8 mm § .41, whereas in cells overexpressing LAP-
PME-1 metaphase spindles were longer (PTP distance D
12.8 mm§ .31, pD 0.02) and those overexpressing LAP-LCMT1
displayed shorter spindles (PTP distance D 7.3 mm § .3, p D
0.0065) (Fig. 3F). However, LAP-PME-1 cells had a similar
Figure 3. Overexpression-mediated perturbation of the LCMT1-PME-1 methylation equilibrium leads to misregulation of spindle size and cell division. (A)
Overexpression of LAP-LCMT1 or LAP-PME-1 compared to non-induced control cells. Note that the levels of demethylated PP2AC decreased in cells over-
expressing LAP-LCMT1 and increased in cells overexpressing LAP-PME-1. (B) Immunofluorescence microcopy showing that LAP-PME-1 overexpression
leads to abnormally long spindles and LAP-LCMT1 overexpression leads to abnormally short spindles. Bar D 5 mm. (C) Quantification of the percentage
of cells in mitosis showing that overexpression of LAP-PME-1 or LAP-LCMT1 leads to a major increase in cells arrested in mitosis. (D) Quantification show-
ing that overexpression of LAP-LCMT1 or LAP-PME-1 leads to a major increase in the percentage of abnormal spindles (short, long, multipolar). (E) Quan-
tification showing that overexpression of LAP-LCMT1 or LAP-PME-1 leads to a major increase in the percentage of unaligned chromosomes. (F)
Quantification of metaphase spindle PTP distance (in mm) showing that LAP-PME-1 overexpression leads to abnormally long spindles and LAP-LCMT1
overexpression leads to abnormally short spindles. (G) Quantification of metaphase spindle width (in mm) showing that overexpression of LAP-LCMT1
leads to a decrease in spindle width, while overexpression of LAP-PME-1 had no significant effect on spindle width. (H) Quantification of metaphase spin-
dle volume (in mm3) showing that overexpression of LAP-PME-1 leads to an increase in volume and LAP-LCMT1 overexpression leads to a decrease in vol-
ume. (I) Quantification of the total fluorescence intensity of mitotic spindle microtubules for LAP-PME-1 or LAP-LCMT1 overexpressing cells, in arbitrary
units (A.U.), showing that overexpression of LAP-LCMT1 leads to a decrease in total microtubule polymer, whereas overexpression of LAP-PME-1 leads to
an increase in total microtubule polymer. (C–I) Data represents average § SDs of 3 independent experiments. * D P < 0.05, ** D P < 0.005, *** D P <
0.0005, ns D not statistically significant.
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spindle width (8.9 mm § .1) to siControl cells (8.8 mm § .25),
whereas the spindle width of LAP-LCMT1 cells was shorter
(6.8 mm § .26, p D 0.0057) (Fig. 3G). Interestingly, the spindle
volume was abnormally large for cells overexpressing LAP-PME-1
(527 mm§ 20.5, pD 0.0066) and abnormally small for cells over-
expressing LAP-LCMT1 (181 mm § 21.5, p D 0.0012), com-
pared to control spindles (434.3 mm§ 14.4) (Fig. 3H). There was
also a reduction in the amount of microtubule polymer (total fluo-
rescence intensity of spindle microtubules in arbitrary units, A.U.)
for cells overexpressing LAP-LCMT1 (317 A.U. § 31, p D 0.05)
and an increase in microtubule polymer for cells overexpressing
LAP-PME-1 (587 A.U.§ 39, pD 0.03) compared to control (438
A.U.§ 53) (Fig. 3I). In addition, overexpression of LAP-LCMT1
led to a decrease in the ratio of demethylated PP2AC (Con-
trolD1 § .06, LAP-LCMT1D0.3 § .02), whereas LAP-PME-1
overexpression led to an increase in the ratio of demethylated
PP2AC (ControlD1 § .01, LAP-PME-1D1.4 § .06) (Fig. 3A;
Fig. S3D and E). These results were consistent with the proposed
model where a LCMT1-PME-1 methylation equilibrium was
responsible for regulating spindle size through the modulation of
PP2ACmethylation (Fig. 1K).
Perturbation of the LCMT1-PME-1 methylation
equilibrium leads spindle assembly checkpoint activation, an
induction of apoptosis and reduced cell viability
Since perturbation of the LCMT1-PME-1-methyaltion equi-
librium led to an increase in unaligned chromosomes at the meta-
phase plate, we sought to understand whether these defects were
due to defects in kinetochore-microtubule attachment. First, we
measured the total amount of cold-stable microtubule polymer
(total fluorescence intensity of cold-stable microtubules, which
form proper kinetochore-microtubule attachments in arbitrary
units (A.U.)) in LCMT1 or PME-1 depleted cells, PME-1 inhib-
ited cells and LAP-LCMT1 or LAP-PME-1 overexpressing cells.
While there was a statistically significant decrease in the fluores-
cence intensity of cold-stable microtubules in PME-1 depleted
cells, PME-1 inhibited cells and LCMT1 overexpressing cells,
there was only a small decrease in LCMT1-depleted and PME-1
overexpressing cells that was not statistically significant (Fig.
S4A–C). However, the lack of a significant difference in
LCMT1-depleted and PME-1 overexpressing cells could have
been due to the fact that these cells had elongated spindles and
thus more tubulin polymer to start with. Thus, we turned to an
alternative assay to analyze kinetochore-microtubule attachment.
Here, we asked if perturbation of the LCMT1-PME-1-methyal-
tion equilibrium could activate the spindle assembly checkpoint
(SAC), which responds to unattached kinetochores or non-pro-
ductive microtubule-kinetochore attachments, by monitoring the
localization of the SAC kinase Bub1 (localizes to the kinetochore
when the SAC is active). Indeed, depletion of LCMT1 or PME-
1, inhibition of PME-1 and overexpression of LAP-LCMT1 or
LAP-PME-1 led to SAC activation even in cells that appeared to
have all their chromosomes aligned at the metaphase plate
(Fig. 4A–C). Together these data indicated that perturbation of
the LCMT1-PME-1-methyaltion equilibrium leads to defects in
microtubule-kinetochore attachment and activation of the SAC.
Next, we asked if the misregulation of spindle size had an
effect on cell viability by measuring the effect of these treatments
on cell viability using the CellTiter-Glo luminescent cell viability
assay, which measured total ATP levels indicative of metaboli-
cally active cells. This analysis revealed that cell viability
decreased in cells with a perturbed methylation equilibrium (nor-
malized percent cell viability for siLCMT1D 66 § 1.45, P
< .005; siPME-1D 66 § 2.24, P < .005; PME-1 inhibition D
62 § 3.2, P < .05); LCMT1 overexpression D 80 § 2.7, P
< .005; PME-1 overexpression D 82 § 1.8, P < .005)
(Fig. 4D–F). Additionally, we analyzed whether this decrease in
cell viability was due to the activation of the apoptotic cell death
pathway by immunoblotting cell lysates for cleaved Caspase 3.
Indeed, perturbation of the methylation equilibrium (through
inhibition/depletion or overexpression of LCMT1 or PME-1)
led to an increase in Caspase 3 cleavage, indicative of apoptosis
(Fig. S5A–C). Together these data indicated that perturbation of
the LCMT1-PME-1-methylation equilibrium led to a caspase-
mediated cell death.
Finally we analyzed the consequences of perturbing the
LCMT1-PME-1 methylation equilibrium by live-cell time-
lapse microcopy. siControl, siLCMT1, siPME-1, control
DMSO, AMZ30, uninduced, LAP-LCMT1 or LAP-PME-1
overexpressing HeLa cells were synchronized in G1/S (thymi-
dine treatment) and released into the cell cycle. Six hours
post-release, cells were imaged at 20X magnification every
15-minutes and images were processed into movie format
(Fig. 5A–C and Supplemental Movies S1-S8). The movies
were then analyzed to determine the percentage of cells that
arrested in mitosis (MA), that displayed defective divisions
(DD) or that died during mitosis (DM) (Fig. 5D–F). Consis-
tent with previous data, perturbation of the methylation equi-
librium led to an increase in the percentage of cells that
arrested during mitosis, that had defective divisions and that
died during mitosis (Fig. 5D–F). Additionally, we quantified
the time spent in mitosis (time length from cell rounding to
cell abscission) for each treatment (Fig. 5G–I). Whereas con-
trol cells transitioned through mitosis within 2 hours, pertur-
bation of the LCMT1-PME-1 methylation equilibrium led to
an increase in the time (hours) cells spent in mitosis
(siLCMT1 D1.61 § .53 (p D 0.0001) and siPME-1
D3.36 § 1.5 (p D 0.0001) compared to siControl D 8.7 §
1.7 (Fig. 5G); AMZ30D 6.37 § 2.3 (p D 0.0001) compared
to DMSO D 1.36 § .42 (Fig. 5H); LAP-LCMT1D 5.46. §
1.59 (p D 0.002) and LAP-PME-1D 4.30 § 1.3 (p D
0.001) compared to control D 1.86 § .48) (Fig. 5I)). These
data were consistent with fixed-cell immunofluorescence
microscopy data and further indicated that changes in spindle
length can lead to increased mitotic arrest and increased cell
death.
Discussion
Our data indicate that LCMT1 and PME-1 are novel fac-
tors important for regulating spindle size and cell division.
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We propose that a balance between LCMT1 methylation and
PME-1 demethylation is critical for controlling spindle size
through the methylation of PP2AC and that misregulating
this equilibrium leads to defective spindle assembly and
decreased cell viability due to activation of the apoptotic
pathway (Fig. 1K). This study increases our understanding of
the enzymatic machinery (LCMT1 and PME-1) that regulates
mitotic spindle size and implicates methylation as an impor-
tant regulatory posttranslational modification for establishing
proper spindle size.
PP2A holoenzyme complexes have varied roles during mitotic
entry, mitotic spindle assembly and mitotic exit.13-16 Although
much of the characterization of PP2A complexes has been carried
out in model organisms like yeast and flies, humans have a larger
number (»15) of regulatory B-subunits (B, B0’, B00, B000), which
further complicates the analysis of the function of PP2A and
studies analyzing the effect of depleting specific B-subunits, and
not the catalytic PP2AC subunit, in mitosis have provided the
most insight into the function of this enzyme.2 Previously, we
systematically depleted each B-subunit from human cells and
analyzed their defects in early mitosis, among the B-subunits
with defects in mitosis was the B type subunit PPP2R2B
(R2B).13 B type subunits (PPP2R2A, PPP2R2B, PPP2R2C,
PPP2R2D) require PP2AC methylation by LCMT1 to bind to
PP2AC and form active holoenzymes, whereas other B-subunits
do not necessitate this posttranslational modification to form
active holoenzymes.2,4 Interestingly, the PP2AC/R1A/R2B
holoenzyme was required for de-phosphorylating the Anaphase
Promoting Complex/Cyclosome (APC/C) subunit Cdc27 to
allow its association with mitotic spindle microtubules to regulate
proper mitotic spindle formation.13 Additionally, cells depleted
of R2B also displayed elongated spindles and spindle multipolar-
ity. Therefore it was possible that the LCMT1-PME-1 methyla-
tion equilibrium was indirectly controlling the phosphorylation
state of the APC/C, and thereby mitotic spindle assembly,
through PP2AC/R1A/R2B.13 Consistent with this idea, wildtype
cells arrested in mitosis with nocodazole maintained Cdc27 in its
expected hyper-phosphorylated form, whereas in AMZ30 treated
cells Cdc27 was dephosphorylated (hypo-phosphorylated) (Fig.
S6). Although preliminary, these results indicate that the
LCMT1-PME-1 methylation equilibrium could potentially act
through regulating the assembly of the PP2AC/R1A/R2B com-
plex and thereby the phosphorylation/dephosphorylation of the
APC/C to control spindle size and should be explored further.
However, there are several other interpretations as to how
PP2A may be regulating spindle size. For example, the B type
subunit PPP2R2A (which is dependent on LCMT1 PP2AC
methylation in order to assemble into the PP2AC/R1A/R2A
holoenzyme) has been implicated in regulating the phosphory-
lation state of the microtubule-associated protein Tau, which
may affect the stability of microtubules and thereby
length.17,18 Although B’ subunits have been implicated in the
regulation of centromere cohesion and the formation of stable
kinetochore-microtubule attachments that could lead to
Figure 4. Analyzing the consequences of perturbing the LCMT1-PME-1 methylation equilibrium. (A–C) Fixed-cell immunofluorescence microcopy show-
ing that the spindle assembly checkpoint is activated (Bub1 remains localized to kinetochores) in LCMT1 or PME-1 depleted cells (A), PME-1 inhibited
cells (B) and LCMT1 or PME-1 overexpressing cells (C). Bar D 5 mm. (D–F) Quantification of normalized percent cell viability for LCMT1 or PME-1-depleted
(D), AMZ30-treated (E), or LCMT1 or PME-1-overexpressing cells (F). Data represents average § SDs of 3 independent experiments. * D P < 0.05, ** D P
< 0.005.
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differences in spindle size, this is unlikely as B0 subunits are not
dependent on PP2AC methylation for holoenzyme assem-
bly.4,19,20 Finally, molecular motors (like Kinesin-5), microtu-
bule polymerization proteins (like XMAP215), microtubule
depolymerization proteins (like Kinesin-8), and microtubule
severing enzymes (like Katanin) have been shown to influence
mitotic spindle size and the signaling pathways,
posttranslational modifications and protein-protein interac-
tions that regulate these factors remain poorly characterized.21-
25 Thus, although PP2AC is the only known direct substrate
that is modified by the LCMT1-PME-1 methylation equilib-
rium, it is still possible that Kinesin-5, Kinesin-8, XMAP215,
Katanin or other proteins that influence microtubule spindle
length could be potential targets of LCMT1/PME-1.
Figure 5. Analyzing the consequences of perturbing the LCMT1-PME-1 equilibrium by live-cell time-lapse microscopy. (A) Live-cell imaging of siControl,
siLCMT1 or siPME-1 treated cells. (B) Live-cell imaging of control DMSO or AMZ30 treated cells. (C) Live-cell imaging of control, LAP-LCMT1 overexpress-
ing or LAP-PME-1 overexpressing cells. (A–C) Bar D 20 mm. Time is in minutes. See also Supplemental Movies S1-S8. (D–F) Quantification of the live-cell
imaging data from A-C for the percentage of cells undergoing mitotic arrest (MA), defective cell divisions (DD) and cell death in mitosis (DM). Data repre-
sents average § SDs of 3 independent experiments. (G–I) Quantification of live-cell imaging data from A-C for the length of time cells spent in mitosis,




HeLa cell culture and synchronizations were as described pre-
viously.26 For pharmacological inhibition of PME-1, cells were
treated with 20 mM AMZ30 for the indicated times.
RNAi
For RNA interference experiments, the following Dharmacon
ONTARGETplus siRNAs: siControl (cat# D-001810-10),
siLCMT1 (pool and individual oligos, cat# L-009425-00, -06,
-07, -08, -09) or siPME-1 (pool and individual oligos, cat# L-
005211-00, -05, -06, -07, -08) were used at 50nM to transfect
HeLa cells using Lipofectamine RNAiMAX as described by the
manufacturer (Invitrogen).
Cloning and generation of LAP-tagged stable cell lines
For full-length LCMT1 and PME-1 expression, full-length
LCMT1 or PME-1 cDNA was fused to the c-terminus of EGFP
(pGLAP1 vector) and vectors were used to generate doxycycline
inducible HeLa Flp-In-T-REx LAP-LCMT1 or PME-1 stable
cell lines that express these proteins from a single locus within
the genome as described previously.12
Antibodies
Immunofluorescence and immunoblotting were carried out
using antibodies that recognize: GFP (Invitrogen cat#A-11120),
Gapdh (Covance cat#MMS-580S), a-tubulin (Serotec cat#M-
CAP77), LCMT1 and PME-1 (Santa Cruz Biotechnology
cat#SC-134675 and cat#SC-25278), PP2AC (Cell Signaling
Technology cat#2038S), de-methylated PP2AC (EMDMillipore
cat#05-577), Caspase 3 (Cell Signaling Technology cat#9665),
Pericentrin (Novus Biologicals cat#NB100-61071), Bub1 (kind
gift from Hongtao Yu). Secondary antibodies conjugated to
FITC, Cy3, and Cy5 were from Jackson Immuno Research
(Affinipure).
Fixed-cell and live-cell microscopy
Fixed-cell immunofluorescence microscopy was carried out as
described previously.13
Except that images were captured with a Leica DMI6000
microscope (Leica DFC360 FX Camera, 63x/1.40-0.60 NA oil
objective, Leica AF6000 software). Images were deconvolved
with Leica Application Suite 3D Deconvolution software and
exported as TIFF files. Live-cell time-lapse microscopy was car-
ried out as described previously.27 Except that Z-stacks were cap-
tured every 1 mm for 10 mm at 20X magnification, and stacks
were deconvolved with Leica Application Suite 3D Deconvolu-
tion software and compressed as maximum intensity projection
images. Images were then converted to movies using QuickTime
software (Apple). Each frame represents a 15-minute interval.
Cell viability and Caspase 3 cleavage assays
The cell viability of cells treated with indicated siRNAs for
72 hours, drugs for 24 hours or induced to overexpress LCMT1
or PME-1 for 48 hours was determined using the CellTiter-Glo
Assay (Promega) as described previously.28 To monitor Caspase
3 cleavage, cells were subjected to the above-mentioned treat-
ments and protein extracts from these cells were analyzed by
immunoblot analysis with anti-Caspase 3 antibodies.
Quantification of data and statistical analysis
For percent abnormal spindles, spindle defects (long, short,
multipolar) were quantified for each treatment (using 100 spin-
dles for each treatment and 3 independent experiments). For
spindle size pole-to-pole measurements, a vector was drawn con-
necting the 2 pericentrin stained poles and the vector distance
(mm) was quantified for each treatment (using 20 spindles for
each treatment in each of 3 independent experiments). Spindle
volume (V D aLAo) measurements in mm3 were quantified as
described previously,22 with 20 spindles for each treatment in
each of 3 independent experiments. Spindle PTP distance and
volume were measured using Leica AF6000 software. The total
fluorescence intensity of spindle microtubules and cold-treated
spindle microtubules was measured 10 spindles for each treat-
ment in each of 3 independent experiments using Leica AF6000
software. For all measurements, data represent the average § SD
of 3 independent experiments. Statistical differences were calcu-
lated using a student’s t-test. P < 0.05 was considered statistically
significant.
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